应焱燕, 崔军, 王永. 2002-2009年浙江省宁波市居民肝癌死亡趋势分析[J]. 疾病监测, 2010, 25(12): 1003-1005. DOI: 10.3784/j.issn.1003-9961.2010.12.024
引用本文: 应焱燕, 崔军, 王永. 2002-2009年浙江省宁波市居民肝癌死亡趋势分析[J]. 疾病监测, 2010, 25(12): 1003-1005. DOI: 10.3784/j.issn.1003-9961.2010.12.024
YING Yan-yan, CUI Jun, WANG Yong. Tend of hepatocarcinoma death in residents in Ningbo, Zhejiang province, 2002 - 2009[J]. Disease Surveillance, 2010, 25(12): 1003-1005. DOI: 10.3784/j.issn.1003-9961.2010.12.024
Citation: YING Yan-yan, CUI Jun, WANG Yong. Tend of hepatocarcinoma death in residents in Ningbo, Zhejiang province, 2002 - 2009[J]. Disease Surveillance, 2010, 25(12): 1003-1005. DOI: 10.3784/j.issn.1003-9961.2010.12.024

2002-2009年浙江省宁波市居民肝癌死亡趋势分析

Tend of hepatocarcinoma death in residents in Ningbo, Zhejiang province, 2002 - 2009

  • 摘要: 目的 了解宁波市居民肝癌死亡率及其发展趋势,为肝癌预防控制工作提供科学依据。 方法 收集整理宁波市居民2002 - 2009年肝癌死亡报告资料,统计分析各年份粗死亡率和标化死亡率、分性别年龄别死亡率等。 结果 2002 - 2009年宁波市居民肝癌死亡19 828例,粗死亡率、标化死亡率分别为44.51/10万、39.74/10万。男女性死亡率均随年龄增长而下降,男性死亡率高于女性,性别比为2.93 ∶ 1。2002 - 2009年男女性死亡率均呈下降趋势。 结论 宁波市居民肝癌发病率处于省内和全国的中上水平,死亡率呈下降趋势,应继续加强病因研究和三级预防工作。

     

    Abstract: Objective To understand the mortality of hepatocarcinoma and its tend in residents in Ningbo and provide evidence for the prevention and control of hepatocarcinoma. Methods The data of death caused by hepatocarcinoma in residents in Ningbo from 2002 to 2009 were collected to analyze annual crude death rate, standardized mortality and sex/age specific mortalities. Results From 2002 to 2009, a total of 19 828 deaths caused by hepatocarcinoma occurred in Ningbo, the crude death rate was 44.51/lakh, the standardized mortality was 39.74/lakh. The mortality declined with aging both in males and females. The mortality in males was 2.93 times than that in females. The mortality of hepatocarcinoma declined from 2002 to 2009. Conclusion The incidence of hepatocarcinoma in residents in Ningbo was at a moderate level compared with provincial and national level, the mortality was in declining. It is necessary to strengthen the etiological research and the three level prevention of hepatocarcinoma.

     

/

返回文章
返回